Ogretmen B - Search Results

1

Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.

Baran Y, Bielawski J, Gunduz U, Ogretmen B. Baran Y, et al. Among authors: ogretmen b. J Cancer Res Clin Oncol. 2011 Oct;137(10):1535-44. doi: 10.1007/s00432-011-1016-y. Epub 2011 Aug 11. J Cancer Res Clin Oncol. 2011. PMID: 21833718

2

Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Postmyocardial Infarction.

Bose RJ, Kessinger CW, Dhammu T, Singh T, Shealy MW, Ha K, Collandra R, Himbert S, Garcia FJ, Oleinik N, Xu B, Vikas, Kontaridis MI, Rheinstädter MC, Ogretmen B, Menick DR, McCarthy JR. Bose RJ, et al. Among authors: ogretmen b. Adv Mater. 2024 Feb;36(8):e2304615. doi: 10.1002/adma.202304615. Epub 2023 Nov 27. Adv Mater. 2024. PMID: 37934471

3

Alterations of lipid-mediated mitophagy result in aging-dependent sensorimotor defects.

Oleinik N, Albayram O, Kassir MF, Atilgan FC, Walton C, Karakaya E, Kurtz J, Alekseyenko A, Alsudani H, Sheridan M, Szulc ZM, Ogretmen B. Oleinik N, et al. Among authors: ogretmen b. Aging Cell. 2023 Oct;22(10):e13954. doi: 10.1111/acel.13954. Epub 2023 Aug 23. Aging Cell. 2023. PMID: 37614052 Free PMC article.

4

Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis.

Janneh AH, Kassir MF, Atilgan FC, Lee HG, Sheridan M, Oleinik N, Szulc Z, Voelkel-Johnson C, Nguyen H, Li H, Peterson YK, Marangoni E, Saatci O, Sahin O, Lilly M, Atkinson C, Tomlinson S, Mehrotra S, Ogretmen B. Janneh AH, et al. Among authors: ogretmen b. Cell Rep. 2022 Dec 6;41(10):111742. doi: 10.1016/j.celrep.2022.111742. Cell Rep. 2022. PMID: 36476873 Free PMC article.

5

Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma.

Kang Y, Sundaramoorthy P, Gasparetto C, Feinberg D, Fan S, Long G, Sellars E, Garrett A, Tuchman SA, Reeves BN, Li Z, Liu B, Ogretmen B, Maines L, Ben-Yair VK, Smith C, Plasse T. Kang Y, et al. Among authors: ogretmen b. Ann Hematol. 2023 Feb;102(2):369-383. doi: 10.1007/s00277-022-05056-7. Epub 2022 Dec 3. Ann Hematol. 2023. PMID: 36460794 Clinical Trial.

6

Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells.

Kraveka JM, Li L, Bielawski J, Obeid LM, Ogretmen B. Kraveka JM, et al. Among authors: ogretmen b. Arch Biochem Biophys. 2003 Nov 15;419(2):110-9. doi: 10.1016/j.abb.2003.08.034. Arch Biochem Biophys. 2003. PMID: 14592454

7

Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas.

Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, Obeid LM, Ogretmen B. Koybasi S, et al. Among authors: ogretmen b. J Biol Chem. 2004 Oct 22;279(43):44311-9. doi: 10.1074/jbc.M406920200. Epub 2004 Aug 17. J Biol Chem. 2004. PMID: 15317812 Free article.

8

Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function.

Sultan I, Senkal CE, Ponnusamy S, Bielawski J, Szulc Z, Bielawska A, Hannun YA, Ogretmen B. Sultan I, et al. Among authors: ogretmen b. Biochem J. 2006 Jan 15;393(Pt 2):513-21. doi: 10.1042/BJ20051083. Biochem J. 2006. PMID: 16201965 Free PMC article.

9

Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.

Senkal CE, Ponnusamy S, Rossi MJ, Sundararaj K, Szulc Z, Bielawski J, Bielawska A, Meyer M, Cobanoglu B, Koybasi S, Sinha D, Day TA, Obeid LM, Hannun YA, Ogretmen B. Senkal CE, et al. Among authors: ogretmen b. J Pharmacol Exp Ther. 2006 Jun;317(3):1188-99. doi: 10.1124/jpet.106.101949. Epub 2006 Mar 1. J Pharmacol Exp Ther. 2006. PMID: 16510697

10

Protein kinase C-induced activation of a ceramide/protein phosphatase 1 pathway leading to dephosphorylation of p38 MAPK.

Kitatani K, Idkowiak-Baldys J, Bielawski J, Taha TA, Jenkins RW, Senkal CE, Ogretmen B, Obeid LM, Hannun YA. Kitatani K, et al. Among authors: ogretmen b. J Biol Chem. 2006 Dec 1;281(48):36793-802. doi: 10.1074/jbc.M608137200. Epub 2006 Oct 9. J Biol Chem. 2006. PMID: 17030510 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters